C
08158
China Regenerative Medicine Inte…
0.38
0.07+22.95%Closed15:40 03/27 HKT
OPEN/PREV CLOSE0.355/0.305
TODAY RANGE0.330-0.395
VOL530.00K
MARKET CAP114.09M
52 WEEK RANGE0.240-1.200
AVG VOL (3M)189.73K
% TURNOVER0.17%
TURNOVER195.55K
P/E (TTM)89.286
% RANGE21.31%
EPS(TTM)0.004
P/E(FORWARD)--
P/B2.133
BVPS0.176
DIVIDEND--
P/S1.584
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP114.09M
SHARES OUTSTANDING304.25M
NEXT EARNINGS--
FREE FLOAT304.25M
LOT SIZE5000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·19h ago
Is Now The Time To Put China Regenerative Medicine International (HKG:8158) On Your Watchlist?
Reuters·02/17 13:28
Waldencast Partners with Aesthetic Record for Obagi ALOHA Program
Reuters·02/06 13:27
Waldencast Partners with DermFx for Obagi ALOHA Program
Reuters·02/05 13:34
Waldencast Partners with Moxie to Launch ALOHA Real-World Evidence Program
Reuters·01/30 13:24
Waldencast Teams Up with VIO Med Spa for Obagi ALOHA Program
Reuters·01/28 13:16
Waldencast Partners with Next Health for Obagi ALOHA Program
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.